Atlas Trials

Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?

Clinical trial NCT05923970 · RECRUITING

Trial details

NCT number
NCT05923970
Sponsor
University of Alberta
Status
RECRUITING
Study type
OBSERVATIONAL
Vaccination FailureVaccine Response Impaired
Start date
2024-11-09
Primary completion
2027-09-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.